OPINION American biotech dominance under threat Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

Republican support for free-market biotech solutions can be won, but we have to focus on the current concerns of voters, instead of merely presenting these arguments as nebulous abstractions.

Chinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough signals China's growing role in global biotech, though ...